Lung Cancer

Switching to E-Cigarettes Not Likely to Prevent Smoking Relapse

By

Jennifer Larson

Publish Date November 18, 2021

An analysis of nationally representative data found that most former smokers who used electronic cigarettes relapsed to cigarette smoking.

Characteristics Identified for Risk of Very Severe irAEs With Immune Checkpoint Inhibitor Therapy

By

Vicki Moore, PhD

Publish Date November 12, 2021

Very severe immune-related adverse events on immune checkpoint inhibitor therapy occur earlier than less severe ones appear to and may have predictors.

Nutritional Status Predictive of Clinical Outcomes, Quality of Life in Patients With Lung Cancer

By

Jessica Nye, PhD

Publish Date November 2, 2021

A meta-analysis with 12 studies demonstrated the effect of nutritional status on outcomes and quality of life for patients with lung cancer.

Trilaciclib Reduced Use of Supportive Care Treatments for Myelosuppression in Extensive-Stage SCLC

By

Jennifer Larson

Publish Date October 28, 2021

A retrospective analysis determined that use of G-CSFs, ESAs, and RBC transfusions were reduced in patients who received trilaciclib prior to chemotherapy for ES-SCLC.

Mobocertinib May Meet Unmet Need in Non-Small Cell Lung Cancer

By

Andrea S. Blevins Primeau, PhD, MBA

Publish Date October 26, 2021

In the platinum-pretreated cohort, the objective response rate was 28%.

Lung Cancer Clinical Trials

Clinical Trial: Protein and RNA Expression Patterns in Predicting Response to Treatment in Patients With Lung Cancer

Clinical Trial: Improving Management of Breathlessness in Patients With Lung Cancer

Clinical Trial: Lung Cancer Screening Study With Low-dose CT Scan and Blood Biomarker

Clinical Trial: Lung Cancer Biomarkers and Screening (NYULCBC)

Clinical Trial: Proton Therapy for Stage I Non-Small Cell Lung Cancer (LU03)